Postmenopausal breast cancer survivors are at increased risk
for developing diabetes and should be screened for the
disease more closely, a new study suggests. Researchers
analyzed data from 1996 to 2008 from the province of
Ontario, Canada, to determine the incidence of diabetes
among nearly 25,000 breast cancer survivors aged 55 or older
and nearly 125,000 age-matched women without breast cancer.
During a median follow-up of more than five years, nearly 10
percent of all the women in the study developed diabetes.
Compared to those who had not had breast cancer, the risk of
diabetes among breast cancer survivors was 7 percent higher
two years after cancer diagnosis and 21 percent higher 10
years after cancer diagnosis, the investigators found. The
risk of diabetes, however, decreased over time among breast
cancer survivors who had undergone chemotherapy. Their risk
compared to women without breast cancer was 24 percent
higher in the first two years after cancer diagnosis and 8
percent higher 10 years after cancer diagnosis, according to
the study. It is possible that chemotherapy treatment may
bring out diabetes earlier in susceptible women. Increased
weight gain has been noted after receiving chemotherapy for
breast cancer, which may be a factor in the increased risk
of diabetes in women receiving treatment, said the study
author. Estrogen suppression as a result of chemotherapy may
also promote diabetes. The study authors suggested that
there may be other factors involved for women who received
chemotherapy, including glucocorticoid drugs, which are used
to treat nausea in patients receiving chemo and are known to
cause spikes in blood sugar. In addition, breast cancer
patients undergoing chemotherapy are monitored more closely
and thus are more likely to have diabetes detected, they
noted. The researchers said it is unclear why diabetes risk
increased over time among breast cancer survivors who did
not receive chemotherapy. There is, however, evidence of an
association between diabetes and cancer, which may be due to
risk factors common to both conditions. One such risk factor
is insulin resistance, which predisposes to both diabetes
and many types of cancer-initially insulin resistance is
associated with high insulin levels and there is evidence
that high circulating insulin may increase the risk of
cancer. Therefore, it is possible that cancer risk occurs
much earlier than diabetes in insulin-resistant individuals,
when insulin levels are high. Overall, the findings support
a need for closer monitoring of diabetes among breast cancer
survivors, researcher concluded. Although the study found an
association between diabetes and breast cancer, it did not
prove a cause-and-effect relationship. |